Barrett Katz

Barrett Katz is the current President and Chief Medical Officer at BridgeBio. Prior to this, they served as the Chief Medical Officer at Viridian Therapeutics, Inc. for 1 year and 7 months. Before that, they were the President and Chief Medical Officer at BridgeBio Pharma, Inc. for 1 year and 8 months. Barrett also served as the Chief Medical Officer at GenSight Biologics for 2 years. Additionally, Barrett Katz is a Professor of Ophthalmology, Neurology and Neurosurgery at Albert Einstein College of Medicine. Barrett has been with the Albert Einstein College of Medicine for 7 years and 10 months and is also the Executive Director of the Office of Clinical Trials and the Institute for Clinical and Translational Research. Prior to their current positions, they were the CEO of Danube Pharmaceuticals, Inc. for 2 years and the CMO of Fovea Pharmaceuticals for 1 year and 10 months. Barrett also served as the VP for Medical Affairs and Medical Strategy at Eyetech Pharmaceuticals for 2 years.